# Efficacy of the RayerKnife X Stereotactic Radiotherapy System in the Treatment of Brain Metastases

> **NCT06852001** · NA · NOT_YET_RECRUITING · sponsor: **Tianjin Medical University Cancer Institute and Hospital** · enrollment: 34 (estimated)

## Conditions studied

- Brain Metastasis
- SRS

## Interventions

- **DEVICE:** X-ray stereotactic radiotherapy for brain metastasis

## Key facts

- **NCT ID:** NCT06852001
- **Lead sponsor:** Tianjin Medical University Cancer Institute and Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2026-03-01
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2025-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06852001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06852001, "Efficacy of the RayerKnife X Stereotactic Radiotherapy System in the Treatment of Brain Metastases". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06852001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*